Healthcare Portfolio

UPDATED ON

Sep 4

Healthcare holds up to 5 names drawn from Healthcare above $200M. Healthcare ranked on the positive head, composite factor and analyst rating. Positions are held for 6-21 days, each position carries a 20% stop-loss. Benchmark: S&P 500 Health Care (S5HLTH).

Description

Healthcare above $200M. Names are ranked on the positive-head score together with the composite positive factor and analyst rating. Holds up to 5 names for 6 to 21 days, with a 20% stop-loss on every position.

Strategy

Equal capital is invested in every stock recommendation. Recommendations are published a few hours before the open, and each one is placed as a market order with a 20% stop-loss attached, so buys and sells fill at the opening price. If the price touches the stop during the day, the position is sold there, at 80% of its entry price. Positions are held for 6 to 21 days. Reported returns are measured from those opening prices and include every stop-loss exit.

View Returns

Holdings:5

New Additions:1

Removed:1

Holdings5

NEW

ALMS

Alumis Inc.

Sector:Healthcare

Industry:Biotechnology

Market Cap:$2.76B

Analysts Target:+41%

Analysts Rating:2.0/5

ForecastQ Daily Probabilities

77.4%

37.3%

67.1%

MGTX

MeiraGTx Holdings plc

Sector:Healthcare

Industry:Biotechnology

Market Cap:$1.28B

Analysts Target:+88%

Analysts Rating:2.0/5

ForecastQ Daily Probabilities

65.7%

58.0%

38.9%

STTK

Shattuck Labs, Inc.

Sector:Healthcare

Industry:Biotechnology

Market Cap:$0.64B

Analysts Target:+87%

Analysts Rating:2.0/5

ForecastQ Daily Probabilities

64.9%

54.5%

45.0%

DFTX

Definium Therapeutics, Inc.

Sector:Healthcare

Industry:Biotechnology

Market Cap:$5.44B

Analysts Target:+58%

Analysts Rating:2.0/5

ForecastQ Daily Probabilities

58.8%

32.2%

40.0%

CGON

CG Oncology Inc.

Sector:Healthcare

Industry:Biotechnology

Market Cap:$6.56B

Analysts Target:+17%

Analysts Rating:2.0/5

ForecastQ Daily Probabilities

66.8%

48.2%

27.8%

Removed Stocks1

REMOVED

GPCR

Structure Therapeutics Inc.

Sector:Healthcare

Industry:Biotechnology

Market Cap:$2.73B

Analysts Target:+129%

Analysts Rating:2.0/5

ForecastQ Daily Probabilities

76.3%

48.7%

47.6%